CPP
BLUE

Crow Point Partners’s bluebird bio BLUE Stock Holding History

Crow Point Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4
Closed -$8K – 136
2018
Q1 		$8K Sell
4
-31
-89% -$78.8K ﹤0.01% 255
2017
Q4 		$82K Buy
+35
New +$71.1K 0.01% 178

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crow Point Partners's BLUE Position: Q2 2018 in Review

Crow Point Partners sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 4 shares — an estimated $8K sold.

Crow Point Partners first reported a position in BLUE in Q4 2017 and held it in 2 quarters. The position peaked at $82K in Q4 2017. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

  • Crow Point Partners reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
  • Crow Point Partners sold 4 bluebird bio shares in Q2 2018, an estimated $8K.
  • Crow Point Partners first reported a position in bluebird bio in Q4 2017 and held it in 2 quarters.
  • Crow Point Partners's bluebird bio position peaked at $82K in Q4 2017.
  • 307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Crow Point Partners's 13F filing for Q2 2018, filed 14 Aug 2018.